Related Experiment Video
Updated: Apr 20, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Comprehensive summary--Predict-IV: A systems toxicology approach to improve pharmaceutical drug safety testing
Stefan O Mueller1, Wolfgang Dekant2, Paul Jennings3
1Nonclinical Safety, Merck Serono, Merck KGaA, Darmstadt, Germany; Institute of Applied Biosciences, Toxicology, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Abstract:
This special issue of Toxicology in Vitro is dedicated to disseminating the results of the EU-funded collaborative project "Profiling the toxicity of new drugs: a non animal-based approach integrating toxicodynamics and biokinetics" (Predict-IV; Grant 202222). The project's overall aim was to develop strategies to improve the assessment of drug safety in the early stage of development and late discovery phase, by an intelligent combination of non animal-based test systems, cell biology, mechanistic toxicology and in silico modeling, in a rapid and cost effective manner. This overview introduces the scope and overall achievements of Predict-IV.
More Related Videos
Related Concept Videos
Toxicokinetics: Overview
Toxicity Testing in Animals
Drug Toxicity: Overview
Drug toxicity: Drug–Drug Interaction
Pharmaceutical Poisoning: Potential Scenarios
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

